These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1439121

  • 1. [Hypertension: when to consider it a risk factor?].
    Pessina AC, Rossi GP.
    Recenti Prog Med; 1992 Sep; 83(9):515-9. PubMed ID: 1439121
    [Abstract] [Full Text] [Related]

  • 2. [Arterial hypertension, correlated factors and cardiovascular risk].
    Pessina AC, Casiglia E, Rossi GP, Semplicini A.
    Cardiologia; 1991 Dec; 36(12 Suppl 1):67-78. PubMed ID: 1841807
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [Abstract] [Full Text] [Related]

  • 4. Na+-Li+ countertransport in human erythrocytes--effects of hypokalaemia, oral contraceptives and antihypertensive medication.
    Beuckelmann D, Meyer HD, Erdmann E.
    Klin Wochenschr; 1985 Jan; 63 Suppl 3():139-42. PubMed ID: 3999632
    [Abstract] [Full Text] [Related]

  • 5. [The intervention trial in the evaluation of antihypertensive therapy].
    Mancia G, Cattaneo BM, Grassi G.
    Ann Ital Med Int; 1995 Oct; 10 Suppl():108S-111S. PubMed ID: 8562256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T, Eon Y, Le Néel H, Seignard H, Battini J.
    Arch Mal Coeur Vaiss; 2005 Oct; 98(7-8):761-6. PubMed ID: 16220744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypertension and diabetes: epidemiologic aspects as a guide to management.
    Fuller JH.
    J Cardiovasc Pharmacol; 1993 Oct; 21 Suppl 2():S63-6. PubMed ID: 7692153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM.
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.